TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
JK Biostatistics AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 2,845 | 2,966 | 2,661 |
Financial expenses | 1 | 3 | 0 |
Earnings before taxes | 153 | 546 | 742 |
EBITDA | 186 | 549 | 685 |
Total assets | 2,127 | 1,531 | 1,451 |
Current assets | 1,730 | 1,339 | 308 |
Current liabilities | 747 | 255 | 339 |
Equity capital | 1,380 | 1,276 | 1,112 |
- share capital | 100 | 100 | 100 |
Employees (average) | 3 | 3 | 2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 64.9% | 83.3% | 76.6% |
Turnover per employee | 948 | 989 | 1,330 |
Profit as a percentage of turnover | 5.4% | 18.4% | 27.9% |
Return on assets (ROA) | 7.2% | 35.9% | 51.1% |
Current ratio | 231.6% | 525.1% | 90.9% |
Return on equity (ROE) | 11.1% | 42.8% | 66.7% |
Change turnover | -121 | 305 | 139 |
Change turnover % | -4% | 11% | 6% |
Chg. No. of employees | 0 | 1 | 0 |
Chg. No. of employees % | 0% | 50% | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.